LAFAYETTE SURGICAL SPECIALTY HOSPITA — History
CCN 190259 | 3-year financial timeline | COVID resilience: 71/100
🛡️ Public data only — no PHI permitted on this instance.
$49M
Latest Revenue (FY2022)
+9.0%
Revenue CAGR (3yr)
9.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $41M | $43M | $49M | +12.8% | +9.0% |
| Operating Expenses | $40M | $40M | $44M | +10.8% | +6.0% |
| Operating Margin | 3.9% | 7.5% | 9.1% | +21.8% | +53.2% |
| Net Income | $2M | $3M | $4M | +37.4% | +67.1% |
| Licensed Beds | 20 | 20 | 20 | +0.0% | +0.0% |
| Total Patient Days | 1,476 | 1,311 | 1,191 | -9.2% | -10.2% |
| Medicare Day % | 27% | 24% | 30% | +25.8% | +6.4% |
| Medicaid Day % | nan% | 0% | 0% | +340.3% | +nan% |
COVID Impact & Recovery
Resilience Score: 71/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +18.8% ($41M → $49M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+9.0%
This Hospital
+7.6%
State Avg
Latest Margin
9.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $53M | 11.7% |
| FY2024 (proj) | $57M | 14.3% |
| FY2025 (proj) | $60M | 16.9% |